|
5 New Job Opportunities
|
|
[Guidance Overview]
Where Are the Section 1411 Notices to Employers?
"[T]he Section 1411 certifications that Marketplaces should be generating are theoretically mandatory.... [T]he Marketplace must notify employers 'within a reasonable timeframe' when a determination is made that one of their employees is eligible for subsidized
coverage.... [E]mployers that do receive certifications are permitted to appeal a subsidy determination.... Given how infrequently these Section 1411 certifications are currently issued, employers receiving them may need to be made aware and prepared." MORE >>
MZQ Consulting, LLC
|
[Guidance Overview]
Transportation Plans Offer Valued Benefits But Pose Challenges for Compliance (PDF)
17 pages. "[1] Common features of qualified transportation plans ... [2] Monthly limits ... [3] Taxation ... [4] Special rules ... [5] Documentation, reporting and disclosure ... [6] Penalties ... [7] State and
local laws." MORE >>
Mercer
|
[Guidance Overview]
Guidance Issued on Minnesota Statewide Paid Earned Sick and Safe Time Law
"Only time worked in Minnesota will require accrual of sick and safe time. ESST hours accrue only during hours worked. ... Employees need not specifically ask to use 'sick and safe time' to use it. Employees may use accrued ESST in 'the smallest increment of time
tracked by the employer's payroll system or four hours, whichever is smaller.' ESST may be used 'at the same time as other protected leave under other state or federal laws.' " MORE >>
Ogletree Deakins
|
[Guidance Overview]
CRS Report: Medicare Part D Prescription Drug Benefit
67 pages. "Of the 65 million Medicare beneficiaries in 2022 who were eligible for Part D, 49.8 million (about 77%) were enrolled in a Part D plan and another 1.3 million (about 2%) had prescription drug coverage through a former employer that received a Part D
subsidy for a portion of the coverage.... The 2022 IRA phases in a number of significant Part D changes from 2023 to 2025, including an annual out-of-pocket cap on Part D enrollee cost sharing, enhanced low-income subsidies, a $35 monthly cap on insulin cost sharing, and an annual limit on premium increases from 2024 to 2029." [R40611 updated Nov. 14, 2023] MORE >>
Congressional Research Service [CRS]
|
HSAs Gain Popularity, But Few Users Invest Assets, and Education Remains Big Concern
"When offered the opportunity, nearly 60% of eligible employees enrolled in the HSA-qualifying health option. Of those that enrolled, 80.1% made contributions to their account ... More than one-third of employers also reported that less than 25% of employees spent their
entire HSA balance in 2022 ... Fewer than 20% of participants invested assets when given the option, and nearly 70% of all HSA assets remain in cash." MORE >>
PLANSPONSOR; free registration may be required
|
Health Benefit Design Innovations for Advancing Health Equity (PDF)
"[This paper summarizes] a series of issue briefs [which] explore how employers are using health plan benefit design innovations to advance health equity -- the challenges they face and the ways they overcome these challenges." MORE >>
Health Equity Committee of the American Academy of Actuaries
|
Pharmacists Say Administration's Limit on Drug Industry Middlemen Backfires
"The Biden administration's first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry's price negotiators is backfiring, pharmacists say. Instead, it's adding to the woes of the independent drugstores it was partly designed
to help. The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug.... The clawbacks have ballooned from about $9 million in 2010 to $12.6 billion in 2021[.]" MORE >>
KFF Health News
|
Competition in Prescription Drug Markets, 2017-2022 (PDF)
22 pages. "In 2022, average cost of a biological product, $174 per prescription, was 3.7 times greater than average cost of a small molecule drug, $48 per prescription. Among the 1,838 small molecule drugs in 2022, 43 percent (796 drugs) had only one
manufacturer ... Between 2017 and 2022, for small molecule drugs, the proportion of drugs with 6+ manufacturers rose while those with a single manufacturer declined over time." MORE >>
Assistant Secretary for Planning and Evaluation [ASPE], U.S. Department of Health and Human Services [HHS]
|
FSA or HSA? What to Consider During Open Enrollment
"Both FSAs and HSAs allow you to put aside money for healthcare expenses in a tax-advantaged way. But they also have a few major differences, including who qualifies, how much you can contribute each year, and how long you can wait to spend the money on qualifying medical
expenses." MORE >>
Savant
|
[Opinion]
The Proposed MHPAEA Regs: A Comment on the Comments
"[A comment letter from the Brookings Institution] expresses concern over the depth of the analysis that is required for each
NQTL [and] provides a useful schematic that fleshes out the particulars. The schematic makes the point that a substantial amount of effort is involved in demonstrating compliance for a single NQTL.... [and] all steps must be repeated for each additional NQTL." MORE >>
McDermott Will & Emery
|
Employee Benefits Jobs |
|
|
|
|
|
|
Press Releases |
Seasoned Litigator Joins The Wagner Law Group
The Wagner Law Group P.C.
|
Trucker Huss Director Clarissa Kang Inducted as a Fellow of the American College of Employee Benefits Counsel
Trucker Huss
|
Employee Fiduciary Launches a Future Value of 401(k) Fees Calculator to Emphasize the Impact of High 401(k) Fees on Retirement Savers' Balances
Employee Fiduciary, LLC
|
Leading Atlanta-Based Benefits Companies Join IMA Financial Group
IMA Financial Group
|
Federal Judge Appoints Independent Fiduciary to Distribute $103K in Assets to Participants in Defunct Ohio Irish Pubs' Retirement Plan
Employee Benefits Security Administration [EBSA], U.S. Department of Labor
|
Health-E Commerce partners® with ŌURA to make Oura Ring available on FSA Store® and HSA Store®
Health-E Commerce
|
|
Last Issue's Most Popular Items |
Common Mistakes in Communications to Employees About Benefits
Buck
|
Eleventh Circuit Affirms District Court's Approval of the BCBSA $2.67 Billion Settlement
Miller Johnson
|
Text of CMS Memo: Application of Pharmacy Price Concessions to the Negotiated Price at the Point of Sale Beginning January 1, 2024 (PDF)
Centers for Medicare & Medicaid Services [CMS], U.S. Department of Health and Human Services [HHS]
|
Unsubscribe |
Change Email Address
Search Past Issues |
Privacy Policy
Submit an Article |
Contact Us |
Advertise Here
Copyright 2023 BenefitsLink.com, Inc. All materials contained in this newsletter are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of BenefitsLink.com, Inc., or in the case of third party materials, the owner of those materials. You may not alter or remove any trademark, copyright or other notices from copies of the content.
BenefitsLink® Health & Welfare Plans Newsletter, ISSN no. 1536-9595.
Links to web sites other than BenefitsLink.com and EmployeeBenefitsJobs.com are offered as a service to our readers. We are not involved in their production and are not responsible for their content.
|